Daridorexant for Alzheimer Disease Prevention
Abroad (travel likely)RecruitingPHASE2
Conditions
Alzheimer Disease (AD)
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Centre StoP-Alzheimer (Douglas Mental Health University Institute - Research Centre), Montreal, Quebec, Canada
Contact: Principal Investigator (Sylvia Villeneuve, PhD)Simon Ducharme, MD, PhD (Sub-investigator)
Study leads
Sylvia Villeneuve, PhD
Principal Investigator
McGill University